Last reviewed · How we verify
NCT07045688
Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
NA trial testing Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection in H. Pylori Infection in 150 participants. Currently enrolling.
25 November 2025
Quick facts
| Lead sponsor | Sohag University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 13 May 2025 |
| Primary completion | 25 November 2025 |
| Estimated completion | 25 November 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection — full drug profile →
- Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection — full drug profile →
- Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection — full drug profile →
Conditions studied
- H. Pylori Infection — all drugs for H. Pylori Infection →
Sponsor
Sohag University
Who can join
19 and older, any sex, with H. Pylori Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07045688
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for H. Pylori Infection
Currently open trials in the same condition.
- NCT07045857 — Recurrence of H Pylori : Incidence and Influential Factors. · NA · recruiting
- NCT07224048 — Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 · Phase 4 · active not recruiting
- NCT05544396 — Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis. · NA · active not recruiting
- NCT05387005 — Screening Strategy for Gastric Cancer Prevention · NA · recruiting
Other Sohag University trials
Trials by the same sponsor.
- NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
- NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
- NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
- NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07045688 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sohag University
- Last refreshed: 1 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07045688.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing